BBC · Virtus Biotech Clinical Trials Etf
ETFis Series Trust I
$41.22
-2.16%
At close · Oct 23
Net assets $46,392,581
Holdings132
1 month
-8.69%
Year to date
+6.90%
52-week range
$28.73–$56.18
30-session avg volume
28,035
Market performance
Adjusted close · up to five years
Fund profile
- Structure
- Open-end / ETF
- SEC series
- S000047353
- Report date
- Jul 31, 2026
- Holdings coverage
- Full reported portfolio
Portfolio concentration
Top 10 holdings14.25%
Calculated only when the SEC filing is stored with complete portfolio coverage.
Asset allocation
EC99.84%
STIV3.48%
Country allocation
US86.66%
KY5.32%
CA3.40%
NL3.00%
IE1.55%
GB1.27%
VG0.80%
Other1.31%
Portfolio holdings
Latest linked SEC Form NPORT-P report.
| Holding | Ticker / CUSIP | Value | Weight |
|---|---|---|---|
| DREYFUS GOVERNMENT CASH MANAGE | 000000000 | $1,612,819 | 3.48% |
| FIRST TRACKS BIOTHERAPEUTICS INC | TRAX | $775,985 | 1.67% |
| MBX BIOSCIENCES INC | MBX | $577,151 | 1.24% |
| ATAIBECKLEY INC | 04650F101 | $569,295 | 1.23% |
| MONOPAR THERAPEUTICS INC | MNPR | $563,420 | 1.21% |
| DEFINIUM THERAPEUTICS INC | DFTX | $546,524 | 1.18% |
| XENCOR INC | XNCR | $509,454 | 1.10% |
| ZENAS BIOPHARMA INC | ZBIO | $493,514 | 1.06% |
| UNIQURE NV | 000000000 | $491,841 | 1.06% |
| APOGEE THERAPEUTICS INC | 03770N101 | $471,863 | 1.02% |
| VOR BIOPHARMA INC | VOR | $457,771 | 0.99% |
| REGENXBIO INC | RGNX | $452,232 | 0.97% |
| LB PHARMACEUTICALS INC | LBRX | $438,315 | 0.94% |
| DAMORA THERAPEUTICS INC | 000000000 | $433,603 | 0.93% |
| AMYLYX PHARMACEUTICALS INC | AMLX | $432,664 | 0.93% |
| DYNE THERAPEUTICS INC | DYN | $430,251 | 0.93% |
| ORUKA THERAPEUTICS INC | ORKA | $429,180 | 0.93% |
| NURIX THERAPEUTICS INC | NRIX | $425,602 | 0.92% |
| ORIC PHARMACEUTICALS INC | ORIC | $416,066 | 0.90% |
| GH RESEARCH PLC | 000000000 | $413,078 | 0.89% |
| SIONNA THERAPEUTICS INC | SION | $407,816 | 0.88% |
| DIANTHUS THERAPEUTICS INC | DNTH | $404,906 | 0.87% |
| ERASCA INC | ERAS | $401,514 | 0.87% |
| JADE BIOSCIENCES INC | JBIO | $400,155 | 0.86% |
| SELLAS LIFE SCIENCES GROUP INC | SLS | $397,347 | 0.86% |
| PALVELLA THERAPEUTICS INC | PVLA | $397,098 | 0.86% |
| RELAY THERAPEUTICS INC | RLAY | $395,223 | 0.85% |
| REPLIMUNE GROUP INC | REPL | $392,011 | 0.84% |
| ALTO NEUROSCIENCE INC | ANRO | $391,865 | 0.84% |
| ADLAI NORTYE LTD | ANL | $391,521 | 0.84% |
| BICARA THERAPEUTICS INC | BCAX | $388,370 | 0.84% |
| IMMUNOME INC | IMNM | $384,894 | 0.83% |
| AVALO THERAPEUTICS INC | AVTX | $384,309 | 0.83% |
| MEIRAGTX HOLDINGS PLC | 000000000 | $382,114 | 0.82% |
| IDEAYA BIOSCIENCES INC | IDYA | $380,738 | 0.82% |
| SPYGLASS PHARMA INC | SGP | $379,743 | 0.82% |
| KODIAK SCIENCES INC | KOD | $379,418 | 0.82% |
| REVOLUTION MEDICINES INC | RVMD | $378,811 | 0.82% |
| CELLDEX THERAPEUTICS INC | CLDX | $378,316 | 0.82% |
| SPYRE THERAPEUTICS INC | SYRE | $378,276 | 0.82% |
| CULLINAN THERAPEUTICS INC | CGEM | $374,336 | 0.81% |
| LEXICON PHARMACEUTICALS INC | LXRX | $373,947 | 0.81% |
| XENON PHARMACEUTICALS INC | XENE | $373,889 | 0.81% |
| KYMERA THERAPEUTICS INC | KYMR | $372,757 | 0.80% |
| BIOHAVEN LTD | 000000000 | $371,979 | 0.80% |
| CG ONCOLOGY INC | CGON | $371,469 | 0.80% |
| NEKTAR THERAPEUTICS | NKTR | $369,887 | 0.80% |
| ENLIVEN THERAPEUTICS INC | ELVN | $369,310 | 0.80% |
| ARCUS BIOSCIENCES INC | RCUS | $368,161 | 0.79% |
| TYRA BIOSCIENCES INC | TYRA | $367,130 | 0.79% |
Showing the top 50 of 132 holdings. Create a free account to see every holding and download the CSV.